Sale of 23,429 shares at $10.9158 per share.
Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code S
Traded Sep 8, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0001193125-26-386431 · filed 2026-09-09 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-09-09. https://desqlong.com/cards/0001193125-26-386431-1 (retrieved 2026-09-26).